Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 9, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.4K

Establishment a CHO Cell Line Expressing Human CD52 Molecule.

Kadijeh Tati1, Mahsa Yazdanpanah-Samani2, Amin Ramezani3

  • 1Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical sciences, Shiraz, Iran; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Reports of Biochemistry & Molecular Biology
|January 11, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between Serum Vitamin D Levels and <i>VDR</i> <i>BsmI</i> Polymorphism in Temporomandibular Joint Dysfunction Patients (in the Iranian Population).

Journal of dentistry (Shiraz, Iran)·2026
Same author

Interleukin-38 serum levels in breast cancer: A comparative analysis of women under 40 and over 50.

Caspian journal of internal medicine·2026
Same author

Adipose-derived mesenchymal stromal cells promote an exhaustion-associated phenotype in T cells through TIM-3 upregulation independent of PD-1.

Discover oncology·2026
Same author

Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells.

PloS one·2026
Same author

Systemic Immune Remodeling in Breast Cancer: Selective Enrichment of TNFR2<sup>+</sup> Circulating Lymphocytes in Breast Cancer.

Breast cancer (Dove Medical Press)·2026
Same author

Mismatch Repair Proteins and CD45RO-Positive Lymphocytes in Malignant and Benign Salivary Gland Tumors: A Favorable Association with Disease Clinical Parameters.

International archives of otorhinolaryngology·2026
This summary is machine-generated.

Researchers cloned and expressed the human CD52 gene in CHO cells, creating a CD52-positive cell line. This advancement aids in developing diagnostic tools and potential antibody therapies for CD52-related conditions.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • CD52 is a GPI-anchored glycoprotein found on lymphocytes and monocytes.
  • Soluble CD52 in chronic lymphocytic leukemia (CLL) plasma may serve as a tumor marker.
  • CD52's precise function is unknown but may influence T-cell migration and activation.

Purpose of the Study:

  • To clone and express the human CD52 gene in a Chinese Hamster Ovary (CHO) cell line.
  • To investigate the functional role of CD52 in more detail.

Main Methods:

  • CD52 gene amplification from Raji cell line cDNA using specific primers.
  • Cloning the amplified gene into the pBudCE4.1 vector, creating the pBudKT1 construct.
  • Transfection of CHO-K1 cells with the construct via electroporation and confirmation of expression using RT-PCR and flow cytometry.
Keywords:
CD52Recombinant DNATherapeutic and diagnostic proteins

More Related Videos

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

15.8K
Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

13.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.4K
Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

15.8K
Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

13.3K

Main Results:

  • Successful amplification and cloning of the CD52 gene, confirmed by PCR and sequence analysis.
  • Detection of CD52 mRNA in transfected CHO cells via RT-PCR.
  • Flow cytometry confirmed CD52 protein expression on the surface of 78.4% of transfected cells.

Conclusions:

  • A human CD52-expressing CHO cell line (CHO-CD52) was successfully established.
  • This cell line serves as a foundation for producing therapeutic monoclonal antibodies against CD52.
  • The development facilitates detection systems for soluble CD52 in biological fluids.